Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × Famotidine × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1

Conditions

Thyroid Cancer, Papillary 1 Neoplasms 1 Melanoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

tovorafenib 1 sargramostim 1 entrectinib 1 cobimetinib 1 alectinib 1 aldesleukin 1 Vemurafenib 1 Taxes 1 Ritonavir 1 Radiotherapy 1 Paclitaxel 1 Nivolumab 1 Indinavir 1 Famotidine 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00451880 2011-10-13

Study of XL281 in Adults With Solid Tumors

Exelixis

Phase 1 Completed

DermatologicEndocrineGastrointestinalHead & NeckThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡